Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort

• Association of IgG N-Glycans With Adverse Outcomes in CKD

  2026 Kidney International Reports article Biochemistry, Genetics and Molecular Biology Glycosylation and Glycoproteins Research Open access

  0

  citations
• Pathophysiologie der Atherosklerose

  2025 Springer Reference Medizin book-chapter Medicine Lipoproteins and Cardiovascular Health

  0

  citations
• Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort

  2024 Clinical Kidney Journal article Medicine Renal Diseases and Glomerulopathies Open access

  6

  citations
• Interactive exploration of adverse events and multimorbidity in CKD

  2024 Nephrology Dialysis Transplantation article Medicine Chronic Kidney Disease and Diabetes Open access

  8

  citations
• Hypertonietherapie bei Nierenerkrankungen

  2024 Nephrologie aktuell article Medicine Blood Pressure and Hypertension Studies

  0

  citations
• Pathophysiologie der Atherosklerose

  2024 Springer Reference Medizin book-chapter Medicine Lipoproteins and Cardiovascular Health

  0

  citations
• Association of mineral and bone biomarkers with adverse cardiovascular outcomes and mortality in the German Chronic Kidney Disease (GCKD) cohort

  2023 Bone Research article Medicine Parathyroid Disorders and Treatments Open access

  22

  citations
• Copeptin, Natriuretic Peptides, and Cardiovascular Outcomes in Patients With CKD: The German Chronic Kidney Disease (GCKD) Study

  2023 Kidney Medicine article Medicine Heart Failure Treatment and Management Open access

  15

  citations
• Cardiovascular risk due to diabetes mellitus in patients with chronic kidney disease—prospective data from the German Chronic Kidney Disease cohort

  2023 Clinical Kidney Journal article Medicine Chronic Kidney Disease and Diabetes Open access

  14

  citations
• Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

  2023 Nature Genetics article Medicine Renal Diseases and Glomerulopathies Open access

  192

  citations
• Differential Prognostic Utility of Adiposity Measures in Chronic Kidney Disease

  2023 Journal of Renal Nutrition article Medicine Cardiovascular Function and Risk Factors Open access

  2

  citations
• Nrf2 Activation Does Not Protect from Aldosterone-Induced Kidney Damage in Mice

  2023 Antioxidants article Biochemistry, Genetics and Molecular Biology Genomics, phytochemicals, and oxidative stress Open access

  5

  citations
• Heart-Type Fatty Acid Binding Protein, Cardiovascular Outcomes, and Death: Findings From the German CKD Cohort Study

  2022 American Journal of Kidney Diseases article Biochemistry, Genetics and Molecular Biology Peroxisome Proliferator-Activated Receptors

  12

  citations
• Educational Attainment Is Associated With Kidney and Cardiovascular Outcomes in the German CKD (GCKD) Cohort

  2022 Kidney International Reports article Medicine Chronic Kidney Disease and Diabetes Open access

  29

  citations
• GWAS defines pathogenic signaling pathways and prioritizes drug targets for IgA nephropathy

  2021 medRxiv preprint Medicine Renal Diseases and Glomerulopathies Open access

  5

  citations
• Low adherence to CKD-specific dietary recommendations associates with impaired kidney function, dyslipidemia, and inflammation

  2021 European Journal of Clinical Nutrition article Medicine Chronic Kidney Disease and Diabetes Open access

  39

  citations

16 results